Nektar Therapeutics CEO Discusses Q4 2012 Results – Earnings Call Transcript

Published March 4, 2013

Nektar Therapeutics CEO Discusses Q4 2012 Results – Earnings Call Transcript

Filed under: drug abuse treatment cost analysis program

On this call, we expect to make forward-looking statements regarding our business, including but not limited to the clinical development program plans and expectations, the timing of future clinical results and regulatory filings by us or our …
Read more on Seeking Alpha

Durect Offers Two Shots On Goal, Almost 100% Upside

Filed under: drug abuse treatment cost analysis program

This is a pesky assay to perform on a drug like Remoxy given that the drug was designed by Durect with its ORADUR technology specifically to not dissolve and release oxycodone at a rate that would create abuse or misuse potential. Nevertheless, an …
Read more on Seeking Alpha

All condemn pending budget cuts, spread blame

Filed under: drug abuse treatment cost analysis program

Work-study jobs: Around 2,170 fewer low income students in Indiana would receive aid to help them finance the costs of college and around 1,020 fewer students will get work-study jobs that help them pay for college. • Head Start: Head Start and Early …
Read more on Palladium-Item